Market Access/ News/ News/ News/ Oncology Simcere gets China okay for G1’s bone marrow protector Cosela Phil Taylor China, Cosela, G1 Therapeutics, Oncology, regulatory approval, Simcere Pharmaceutical 0 Comment China’s Simcere Pharmaceutical has been granted approval in its home market for Cosela, a drug designed to limit Share X Simcere gets China okay for G1’s bone marrow protector Cosela https://pharmaphorum.com/news/simcere-gets-china-okay-for-g1s-bone-marrow-protector-cosela/